Kelly Jared
- SEC CIK
- 0002103581
In the past year, 2 open-market purchase filings worth $34.3K and no sales.
Current role at each company
- ONCY Oncolytics Biotech IncChief Executive Officeras of Jun 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $34.3K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$34.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kelly Jared as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 (view filing) | Mar 12 | 1 day | Kelly JaredChief Executive Officer | PPurchase | +5.05K | $0.96 | +$4.85K | +4.6%114.0K after | |
| Feb 13, 2026 (view filing) | Feb 11-12 | 2 days | Kelly JaredChief Executive Officer | PPurchase | +35.1K | $0.84 | +$29.5K | +47.5%109.0K after | 2 lots |